The ams OSRAM SFH 7018 Enables Improved Quality of Heart Rate and Blood Oxygen Measurements for Wearables

The new SFH 7018 red/green/IR LED increases total radiant intensity by more than 40 percent over the previous generation product. The green emitter’s radiant intensity is more than 100 percent higher in one of the two versions of the product. Internal research shows that the SFH 7018 is one of the highest performing products on the market.

Brighter LEDs in combination with two-cavity design enable higher accuracy for heart rate and blood oxygen saturation measurements.

The compact form factor and the optimal LED spacing improve system performance and increase ease-of-integration into end-product designs.

PREMSTAETTEN, Austria & MUNICH–(BUSINESS WIRE)–ams OSRAM (SIX: AMS), a global leader in intelligent sensing and emitting, released a new multi-LED package which offers more than 40 percent higher radiant intensity than the previous generation product, resulting in higher accuracy PPG (photoplethysmography) measurements in smart watches, wristbands and other wearable devices.


The SFH 7018 features a highly reflective QFN (Quad Flat No Leads) package for significantly increased light output. In addition, an improved two-cavity design separates the green LED from the red LED and infrared (IR) LED: the spacing and optical isolation ensure that the light sources are optimally placed relative to their photodiodes and reduce interference between the green light (for heart rate measurements) and the red light and IR source (for blood oxygen saturation, or SpO2, measurements). Furthermore, the green chip does not cause the red and IR chips to fluoresce due to cross-excitation from the shorter wavelength.

The optimized form factor of the surface-mount QFN package – just 0.6 mm high – makes it easy to integrate the module into any type of wearable device. Despite its compact size, the SFH 7018 provides dual driving capability with optimized forward voltage headroom and reduced overall power consumption.

Dr. Sergey Kudaev, Senior Staff System Architect at ams OSRAM, said: ‘By using the new SFH 7018, manufacturers of wearable devices can dramatically improve the quality of the optical signals on which heart rate and blood oxygen measurements are based, making them more accurate and reliable in all operating conditions. The SFH 7018 can help to transform vital signs measurements into accurate and absolute determinations of heart rate, blood oxygen levels and even more advanced parameters, such as blood pressure.’

Higher radiant intensity increases the signal-to-noise ratio

The SFH 7018’s improvement in radiant intensity is dramatic: the red and IR LEDs are more than 40 percent brighter than in the existing SFH 7016, and the green LED in the SFH 7018A version of the product is 80 percent brighter, while in the SFH 7018B version, the green LED is more than twice as bright. The brightness of the SFH 7018 at each of the red, green and IR wavelengths also greatly exceeds that of today’s best-performing competing product.

Since all vital signs monitoring devices face the challenge to detect little modulations of already small light signals, the result of scattering and absorption in tissue (depending on various factors), the amount of light emitted by the LEDs strongly affects system performance. When more light is modulated by the blood flow and subsequently reaches the photodiode, signal quality improves, yielding higher accuracy and better repeatability of measurements. The SFH 7018 enables this superior performance by emitting more light into the body.

The SFH 7018 is available in two versions: SFH 7018A is optimized for low forward voltage at high currents, allowing for operation without a costly voltage booster. SFH 7018B is optimized for maximum radiant intensity.

Both variants are in volume production now.

More information on OSRAM SFH 7018 | ams OSRAM (ams-osram.com)

Join ams OSRAM social media channels: >Twitter >LinkedIn >Facebook >YouTube

Contacts

Media Relations
Nina Olumi

Tel: +49 89 6213-3586

[email protected]
[email protected]
ams-osram.com

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.